Surgical Techniques in Diabetes Mellitus-II and Obesity. Metabolic Surgery Study (MSS)
NCT ID: NCT02310555
Last Updated: 2014-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2014-10-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric bypass
classic Gastric bypass
Gastric bypass
Modified gastric bypass.
Modified gastric bypass. Resection body and fundus gastric
Modified gastric bypass.
Slevee Gastrectomy
Slevee Gastrectomy
Slevee Gastrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastric bypass
Modified gastric bypass.
Slevee Gastrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes Mellitus type II less than 10 years of evolution.
* Anti-GAD, anti-pancreatic islets negative antibodies.
* C peptide normally between 0.9 and 4.
* Glycosylated hemoglobin greater than 6.5%.
* Less than 5 years of use insulin.
Exclusion Criteria
* coagulopathies.
* Type 1 diabetes.
* HIV positive.
* Stomach or small intestine previous surgeries .
* Diseases of the exocrine pancreas: pancreatitis, pancreatectomy, neoplasia, cystic fibrosis, hemochromatosis.
* Endocrinopathies: acromegaly, glucagonoma, Cushing's syndrome, pheochromocytoma, hyperthyroidism, somatostatinoma, aldosteronoma.
* Genetic syndromes with diabetes.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Virgen de la Arrixaca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juan Lujan
Section chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan A. Luján Mompean, Ph D; Section chief
Role: PRINCIPAL_INVESTIGATOR
Hospital Clínico Universitario Virgen Arrixaca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínico Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Juan A. Luján Mompean, Ph D; Section chief
Role: CONTACT
Phone: 968369677
Pascual Parrilla Paricio, Ph D; Department head
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Juan A. Luján, Ph D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCUVA-MSS-JL
Identifier Type: -
Identifier Source: org_study_id